[Oncogene products inhibitors in the treatment of cancer].
Katedra i Klinika Hematologii, Onkologii i Chorób Wewnetrznych Akademii Medycznej w Warszawie.
Wieslaw Wiktor
WW
Jedrzejczak
Daria
D
Nurzyńska
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D000068877:Imatinib Mesylate; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics; D015513:Oncogene Proteins / Q000037:antagonists & inhibitors*; D009857:Oncogenes / Q000187:drug effects* / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D015513:Oncogene Proteins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate